Q: Bell's palsy A: I now have rich, comprehensive content from multiple authoritative sources. Let me compile the full answer. --- Bell's Palsy Bell's palsy is the most common disorder of the facial nerve CN VII - an idiopathic, acute-onset, unilateral peripheral facial paralysis that affects roughly 1 in 60 people over a lifetime, with an annual incidence of approximately 23-25 per 100,000. --- Epidemiology & Risk Factors - Affects men and women roughly equally at all ages - Risk factors: Diabetes mellitus, pregnancy especially the third trimester and first 2 weeks postpartum - up to 3x increased risk, and possibly hypertension - Recurrence occurs in approximately 7-8% of cases; average interval between episodes 10 years --- Pathophysiology The condition is not truly idiopathic - a viral mechanism is now established with reasonable certainty for most cases: - Herpes simplex virus type 1 HSV-1 is the primary culprit. PCR has detected HSV-1 DNA in endoneurial fluid surrounding CN VII in the majority of Bell's palsy cases, and in the geniculate ganglion. Mouse models show that inoculating HSV into the ear/tongue replicates facial paralysis. - Varicella-zoster virus VZV accounts for up to one-third of cases when there is no visible rash, it is still Bell's palsy; with a rash it becomes Ramsay Hunt syndrome. - SARS-CoV-2 and HIV seroconversion have also been implicated less commonly. - The likely mechanism: viral reactivation in the geniculate ganglion → inflammation and edema of CN VII → nerve entrapment within the tight bony facial canal → ischemia and axonal injury. Histology shows mononuclear inflammatory infiltrate lymphocytes in the nerve, consistent with an infectious/immune process. --- Clinical Features Feature Detail ------ Onset Acute; maximum weakness by 48 hours in 50%, and virtually all within 3-4 days Weakness pattern All ipsilateral facial muscles - upper AND lower face frontalis, orbicularis oculi, lower face Retroauricular pain Precedes paralysis by 1-2 days in many patients Taste disturbance Loss of taste on anterior 2/3 of tongue chorda tympani involvement - common but rarely persists beyond 2 weeks Hyperacusis Ipsilateral - indicates stapedius muscle paralysis Facial numbness Subjective fullness/numbness; rarely true hypoesthesia in trigeminal distribution Eye Lagophthalmos incomplete eye closure, Bell's phenomenon upward deviation of eyeball on attempted closure Key distinction from UMN central lesions: In Bell's palsy LMN, the forehead is involved frontalis weakness. In UMN lesions stroke, the forehead is SPARED because upper facial muscles receive bilateral corticobulbar innervation. --- Clinical images !Left-sided Bell's palsy - lagophthalmos, obliteration of nasolabial fold, and commissure deviationhttps://cdn.orris.care/cdssimages/pmcclinicalVQAbbf216c740048bf4d37f1b5eeed0d96af1b81e003fdbc9a4b243167411024fae.jpg Classic left-sided peripheral facial palsy: lagophthalmos with Bell's phenomenon, flattened nasolabial fold, commissure deviation to the right House-Brackmann Grade IV !Right-sided Bell's palsy - House-Brackmann Grade V, severe resting asymmetryhttps://cdn.orris.care/cdssimages/pmcclinicalVQA8c9b333bfecae637383eb2bd8a3bb0895d2fbd0ddaa384d24f8eb469bdba2c7a.jpg --- MRI Findings Gadolinium-enhanced T1 MRI characteristically shows diffuse smooth linear enhancement of the facial nerve geniculate ganglion, tympanic and mastoid segments without a mass lesion. More pronounced enhancement correlates with worse prognosis. !Gadolinium-enhanced MRI showing left facial nerve enhancement in Bell's palsy - genu, tympanic, and mastoid segments Harrison's, Fig 452-4https://cdn.orris.care/cdssimages/129aa25d53bc499594c98aaf454d256508a517bf2463d650aac57ac0bbffceef.png Axial and coronal T1 post-gadolinium with fat suppression: diffuse smooth enhancement of the left facial nerve arrows. Note: similar findings can occur in Lyme disease, sarcoidosis, and perineural malignant spread. --- Differential Diagnosis Must actively exclude before labelling "idiopathic Bell's palsy": Cause Clue ------ Ramsay Hunt syndrome VZV reactivation Vesicular rash in external auditory canal, palate, tongue; CN VIII often affected Lyme disease Tick exposure, erythema migrans, can cause bilateral palsy; CSF pleocytosis HIV seroconversion Risk factors; CSF pleocytosis Sarcoidosis Bilateral facial palsy, elevated ACE, bilateral hilar adenopathy Guillain-Barré syndrome Bilateral palsy, ascending weakness, CSF albuminocytologic dissociation Parotid/acoustic tumors Gradual onset, mass on exam Leprosy Endemic area exposure Melkersson-Rosenthal syndrome Recurrent palsy + facial edema + fissured tongue Diabetes, connective tissue disease, amyloidosis Systemic features --- Investigations Diagnosis is clinical in typical cases with no red flags. In atypical or uncertain cases: - ESR / CRP - Fasting glucose screen for diabetes - Lyme serology endemic areas - accounts for ≥10% of facial palsy in endemic zones - HIV serology - Serum ACE + chest imaging sarcoidosis - MRI brain + temporal bones with gadolinium - Lumbar puncture if Guillain-Barré suspected - EMG/nerve conduction after 10 days: denervation potentials indicate axonal degeneration, predicting 3+ months to recovery --- Treatment 1. Corticosteroids First-line, ESSENTIAL - Prednisone 60-80 mg/day for 5 days, then taper over 5 days Harrison's 22e - Alternatively: prednisolone 25 mg twice daily for 10 days Goldman-Cecil - Must be started early within 72 hours of onset ideally - Improves rate of complete recovery from 63% to 83% at 3 months - Mechanism: reduces edema and swelling of the nerve in the facial canal 2. Antivirals - Acyclovir 400 mg 5x/day for 10 days or valacyclovir 1000 mg/day for 5-7 days - Most large RCTs including Sullivan et al. found no added benefit of antivirals over steroids alone in the general Bell's palsy population - However, antivirals should be added when: - Vesicular lesions are observed in the external ear canal or palate Ramsay Hunt - Complete facial paralysis at presentation some evidence for additive benefit - Hato et al. - A 2025 meta-analysis PMID 39724817https://pubmed.ncbi.nlm.nih.gov/39724817/ re-examined glucocorticoids + antivirals vs. glucocorticoids alone across RCTs 3. Eye care Mandatory - Artificial tears during the day - Paper tape / eye patch at night to close the eyelid and prevent corneal exposure - Lubricating ointment 4. Physiotherapy - Facial exercises and neuromuscular re-education - A 2025 systematic review PMID 39647183https://pubmed.ncbi.nlm.nih.gov/39647183/ supports physical therapy for idiopathic facial paralysis 5. Surgery - Surgical decompression of the facial nerve is not recommended and may be harmful Adams & Victor - Cosmetic reconstruction fascia lata slings, nerve grafting reserved for permanent paralysis --- Grading The House-Brackmann scale Grade I = normal; Grade VI = complete paralysis is the standard tool for grading severity and tracking recovery. --- Prognosis Outcome Data ------ Complete recovery 70% within 1-2 months Near-normal function 85% overall Poor recovery 10% have little/no recovery Recurrence 7-8% Favorable prognostic signs: - Incomplete paralysis in the first week strongest predictor - Return of taste in the first week - Any voluntary motor movement within 5-7 days Poor prognostic signs: - Complete paralysis from onset - Pronounced gadolinium enhancement on MRI - EMG evidence of denervation after 10 days predicts delayed, potentially incomplete recovery over months to years Complications of aberrant regeneration: - Synkinesis - involuntary co-contraction e.g., eye closure when chewing - "jaw winking" - Crocodile tears - lacrimation when eating aberrant salivary fibers reinnervate lacrimal gland --- Sources: Adams and Victor's Principles of Neurology 12th Ed., Harrison's Principles of Internal Medicine 22E 2025, Goldman-Cecil Medicine; recent systematic reviews PMID 37940744https://pubmed.ncbi.nlm.nih.gov/37940744/, 39724817https://pubmed.ncbi.nlm.nih.gov/39724817/, 39647183https://pubmed.ncbi.nlm.nih.gov/39647183/.